- 专利标题： ANTI-PD-L1 ANTIBODY PREPARATION
-
申请号： US17297719申请日： 2019-11-26
-
公开(公告)号： US20230287122A1公开(公告)日： 2023-09-14
- 发明人: Liang XIAO , Liping DENG , Haiyu HUANG , Qigang LIU , Liping LIU , Dalton GUO , Tongtong XUE , Jingyi WANG
- 申请人： HARBOUR BIOMED THERAPEUTICS LIMITED , SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
- 申请人地址： CN Hong Kong
- 专利权人： HARBOUR BIOMED THERAPEUTICS LIMITED,SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
- 当前专利权人： HARBOUR BIOMED THERAPEUTICS LIMITED,SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
- 当前专利权人地址： CN Hong Kong; CN Chengdu, Sichuan
- 优先权： CN 1811441890.4 2018.11.29
- 国际申请： PCT/CN2019/121069 2019.11.26
- 进入国家日期： 2021-05-27
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61K47/02 ; A61K47/26 ; A61K47/22 ; A61K9/08 ; A61K39/395
摘要：
Provided is an anti-PD-L1 antibody preparation, including an anti-PD-L1 antibody, a buffer solution and sodium chloride, without added sugars and/or sugar alcohols. Also provided is the use of the anti-PD-L1 antibody preparation in the preparation of drugs for preventing and/or treating and/or adjuvant treating and/or diagnosing a tumor or anemia.
信息查询
